cp wire

CP Wire Articles

More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer
  • Keytruda was studied as monotherapy
  • Overall response rate of 18.7%
  • In patients whose tumors expressed PD-L1 overall response rate was 35.7%

Merck (NYSE: MRK),... read more

Mon, 06/4/18 - 09:12 am
Encorafenib and Binimetinib Combination Results Show Improved Survival in Braf-Mutant Advanced Melanoma Patient
  • Median overall survival for combination 33.6 months vs 16.9 for control
  • Two year overall survival was 58%
  • Results selected for “Best of ASCO” program


Pierre... read more

Mon, 06/4/18 - 08:54 am
Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

Pfizer Inc. (NYSE:PFE) announced on 6/1/2018 the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing... read more

Fri, 06/1/18 - 09:56 am
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
  • 10 new cohorts added
  • 8 cohorts added in January of 2018
  • Trial could include up to 640 patients total


Exelixis, Inc. (Nasdaq:EXEL) announced on 6/1/2018 an... read more

Fri, 06/1/18 - 09:37 am
Siolta Therapeutics and CoreBiome – a Look at Two Different Ways Biotech is Developing Microbiome Related Products

Siolta Therapeutics is focused on treating inflammatory and allergic diseases via live biotherapeutics (LBTs) to improve the functioning of the gut microbiome. They are working to develop... read more

Thu, 05/31/18 - 09:59 am

Pages